experspadmin

Risk Stratification in Mantle Cell Lymphoma: Points for Patient Discussion
Oncology

Risk Stratification in Mantle Cell Lymphoma: Points for Patient Discussion

patient care perspectives
By Christopher Flowers, MD, MS
Evaluating Options for Second-line Treatment of Mantle Cell Lymphoma
Oncology

Evaluating Options for Second-line Treatment of Mantle Cell Lymphoma

patient care perspectives
By Christopher Flowers, MD, MS
Real-World Data on Mantle Cell Lymphoma and Its Treatment
Oncology

Real-World Data on Mantle Cell Lymphoma and Its Treatment

clinical topic updates
By John P. Leonard, MD
First and Second Generations of Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma
Oncology

First and Second Generations of Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma

clinical topic updates
By Anita Kumar, MD
Switch Control Kinase Inhibition: Targeting the Kinase Differently to Thwart Drivers of Resistance
Oncology

Switch Control Kinase Inhibition: Targeting the Kinase Differently to Thwart Drivers of Resistance

expert roundtables
By Arun Singh, MD; Jonathan C. Trent, MD, PhD; Michael C. Heinrich, MD
Load More